BeStock  
Stocks › Biotechnology › RARE

Ultragenyx Pharmaceutical RARE

US equityMarket cap rank #2801Biotechnology
$16.48 −$0.74 (-4.30%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $16.50 +0.12%
Open$16.94
Prev close$17.22
Day range$16.43 – $17.35
Volume3.01M
Market cap$1.68B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

RARE at a glance

Ultragenyx Pharmaceutical (RARE) is trading at $16.48, down 4.30% on the day. Its market value of $1.68B makes it the 2801st largest of the 3753 companies we follow.

Over the past 52 weeks it has traded between $12.73 and $39.89, so it sits 58.7% below the top of that range. Holders are behind 50.9% over twelve months, and down 35.9% across the last three months.

Price is above the 50-day average ($15.51) but below the 200-day ($22.34); RSI is 51, and the last 30 sessions moved at roughly 59% annualized volatility.

For the quarter ended Sep 2026 it reported $173.00M in revenue, up 8.1% from a year earlier, and a net loss of $118.00M.

19 analysts follow the stock and the average call is "buy". The mean target, $25.39, sits 54.1% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$16.50 / $17.39
Average price today$16.62
Volume3.01MAvg (90d) 3.93M
Turnover$50.02M
Turnover rate3.60%of shares outstanding
Volume ratio0.72vs. recent average pace
Day amplitude5.37%
Market cap$1.68B
Float market cap$1.38B
Shares outstanding83.54M
EPS (TTM)-$5.83
P/B-4.47
Book value / share-$3.69
Net profit (TTM)-$594.22M
Net assets-$376.00M
30-day volatility58.7%annualized
Avg daily range (ATR)5.75%of price, 14 days
Max drawdown (1y)-64.8%-54.9% from 1y peak

Quote as of Nov 21, 2026 9:10 am ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

D
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

19 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 5.0 · 2026-11-22 14:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability13.8
Momentum6.4
Financial health60.7
Analyst view47.9

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$25.39+54.1% vs. current price
Consensus ratingBuy19 analysts covering
Morningstar fair value$20.84Price is below fair value

Wall Street’s average 12-month target is $25.39, 54.1% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $20.84, so shares trade 20.9% below that estimate. On earnings multiple, it sits in the 96th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-4.3%
1 week
+2.5%
1 month
+3.3%
3 months
-35.9%
6 months
-29.5%
Year to date
-28.3%
1 year
-50.9%
Day range
$16.43$17.35
52-week range
$12.73$39.89

Technical signals

Full technicals →
Trend readLeaning bearish

3 bullish · 4 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average0.0%Bearish
Price vs 50-day average+6.3%Bullish
Price vs 200-day average-26.2%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)50.6Bullish
MACD (12,26,9)0.19Bullish
Bollinger band position50%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How RARE ranks on BeStock

Market value#2789 of 3734
Closeness to 52-week high#3291 of 3724
Dollar volume today#1420 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

RARE is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on RARE.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on RARE

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

RARE stock: common questions

Where is RARE trading right now?

$16.48 is the latest print for RARE, a move of -4.30% against yesterday's close of $17.22. Today's low and high so far: $16.43 and $17.35.

What is RARE worth in total?

Equity value comes to $1.68B at the current price. By that measure it is number 2801 of the 3753 names in our coverage.

Where does RARE sit in its 52-week range?

The year's floor is $12.73 and the ceiling $39.89. Shares are 58.7% away from that ceiling.

Does RARE send cash back through a dividend?

Our data shows no dividend paid by Ultragenyx Pharmaceutical over the trailing twelve months.

Do Wall Street analysts like RARE?

Of 19 analysts, 47% say buy, 53% hold and 0% sell. Price targets average $25.39, with the most cautious at $16.00 and the most optimistic at $39.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on RARE.

Sign in to join the discussion.

Scroll to Top